Lord, Abbett & Co. LLC Vera Therapeutics, Inc. Transaction History
Lord, Abbett & Co. LLC
- $31.6 Billion
- Q4 2024
A detailed history of Lord, Abbett & Co. LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 1,153,670 shares of VERA stock, worth $33 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,153,670
Previous 426,014
170.81%
Holding current value
$33 Million
Previous $18.8 Million
159.1%
% of portfolio
0.15%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$160 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$125 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$95.4 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$84.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$84.3 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $773M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...